HANGZHOU TIGERMED CONSULTING CO., LTD Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd Hong Kong S.E.
Equities
3347
CNE1000040M1
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.1 HKD | -3.44% |
|
-3.70% | -0.71% |
| 04-25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
| 04-25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
ETFs positioned on Hangzhou Tigermed Consulting Co., Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.29% | 4 M€ | -27.92% | ||
| 0.59% | 2 M€ | -12.23% | - | |
| 0.07% | 2 M€ | -.--% | ||
| 0.03% | 7 M€ | -.--% | - | |
| 0.03% | 35 M€ | -5.85% | - | |
| 0.02% | 112 M€ | +5.41% | - | |
| 0.01% | 454 M€ | +9.82% | - | |
| 0.01% | 153 M€ | +9.25% | - | |
| 0.01% | 2,867 M€ | +11.35% | - | |
| 0.01% | 45 M€ | 0.00% | - | |
| 0.01% | 32 M€ | +9.08% | - | |
| 0.00% | 7 M€ | +6.58% | - | |
| 0.00% | 391 M€ | +9.28% | - | |
| 0.00% | 105 M€ | +4.03% | - | |
| 0.00% | 34 M€ | +3.87% | - | |
| 0.00% | 15 M€ | +18.83% | ||
| 0.00% | 54 M€ | +1.01% | - |
Hangzhou Tigermed Consulting Co, Ltd. specialises in providing professional services to pharmaceutical and biotech companies. The group supports its clients in all processes of clinical development and product commercialization. Net sales break down by activity as follows:
- provision of clinical trial services and related technological services (51.8%);
- provision of clinical research consulting services (48.2%).
China accounts for 46% of sales.
Calendar
2024-05-23
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
56.99
CNY
Average target price
72.84
CNY
Spread / Average Target
+27.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
- Stock Market
- Equities
- 300347 Stock
- 3347 Stock
- Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd
